|
| Light condition | Overexpressed genes after irradiation | Possible cancers affected |
|
| Blue | BUB1B | Brain and lung cancers |
| BMPR1A | Polyposis syndrome, hereditary mixed, 2 and polyposis, juvenile intestinal |
| EHBP1 | Prostate cancer, hereditary, 12 and prostate cancer |
| EPHB2 | Prostate cancer/brain cancer susceptibility, somatic and prostate cancer |
| FANCD2 | Breast cancer and Fanconi anemia |
| KDR | Hemangioma, capillary infantile and hemangioma |
| PDE11A | Pigmented nodular adrenocortical disease, primary, 2 and primary pigmented nodular adrenocortical disease |
| RET | Multiple endocrine neoplasia iia and medullary thyroid carcinoma, familial |
| RUNX1 | Platelet disorder, familial, with associated myeloid malignancy and isolated delta-storage pool disease (among its related pathways are endometrial cancer and chronic myeloid leukemia) |
|
| Green | EPHB2 | Prostate cancer/brain cancer susceptibility, somatic and prostate cancer |
| NF1 | Neurofibromatosis-Noonan syndrome and neurofibromatosis, type 1 |
| SDHC | Paragangliomas 3 and paraganglioma and gastric stromal sarcoma (among its related pathways are Alzheimer’s disease and carbon metabolism) |
|
| Red | AXIN2 | Oligodontia-colorectal cancer syndrome and colorectal cancer |
| EHBP1 | Prostate cancer, hereditary, 12 and prostate cancer |
| EPHB2 | Prostate cancer/brain cancer susceptibility, somatic and prostate cancer |
| GLMN | Glomuvenous malformations and glomangioma |
| GPC3 | Simpson-Golabi-Behmel syndrome, type 1 and Wilms tumor susceptibility-5 |
| KDR | Hemangioma, capillary infantile and hemangioma |
| KIT | Endometrial cancer in gastrointestinal stromal tumor |
| MSMB | Prostate cancer, hereditary, 13 and prostate cancer |
| MSR1 | Prostate cancer and Barrett esophagus/esophageal adenocarcinoma |
| PDGFRA | Gastrointestinal stromal tumor and hypereosinophilic syndrome, idiopathic, resistant to imatinib |
| RUNX1 | Platelet disorder, familial, with associated myeloid malignancy and isolated delta-storage pool disease (among its related pathways are endometrial cancer and chronic myeloid leukemia) |
|
